Screener
CRISPR Therapeutics CRSP Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: CRISPR Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:48 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204188
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Shareholders’ equity: | ||
| Common shares, CHF 0.03 nominal value, 132,477,166 shares authorized at March 31, 2026 and at December 31, 2025, 96,500,822 and 96,009,657 shares issued at March 31, 2026 and December 31, 2025, respectively, 96,385,506 and 95,894,341 shares outstanding at March 31, 2026 and December 31, 2025, respectively | 3,115 | 3,087 |
| Treasury shares, at cost, 115,316 shares at March 31, 2026 and at December 31, 2025 | (60) | (60) |
| Additional paid-in capital | 3,883,924 | 3,861,516 |
| Accumulated deficit | (2,070,482) | (1,947,551) |
| Accumulated other comprehensive (loss) income | (1,941) | 4,821 |
| Total shareholders’ equity | 1,814,556 | 1,921,813 |
| Total liabilities and shareholders’ equity | $2,725,820 | $2,265,243 |
Item 1. Financial Statements
FAQ
- What is CRISPR Therapeutics's total equity?
- CRISPR Therapeutics (CRSP) reported total equity of $1.81B in Q1 2026.
- How has CRISPR Therapeutics's total equity changed year-over-year?
- CRISPR Therapeutics's total equity decreased by 0.8% year-over-year, from $1.83B to $1.81B.
- What is the long-term trend for CRISPR Therapeutics's total equity?
- Over 5 years (2020 to 2025), CRISPR Therapeutics's total equity has grown at a 2.9% compound annual growth rate (CAGR), from $1.66B to $1.92B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about CRISPR Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude